Sarcopenic obesity is significantly associated with poorer overall survival after liver transplantation: a systematic review and meta-analysis

BackgroundSarcopenia has been shown to worsen survival after liver transplantation. However, it remains unclear whether coexisting sarcopenia and obesity, so-called sarcopenic obesity (SO), may also synergistically increase their adverse effects. This meta-analysis aimed to evaluate whether pre-tran...

Full description

Saved in:
Bibliographic Details
Main Authors: Hui-Bin Huang, Yi-Bing Zhu, Da-Xing Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2024.1387602/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846119829108424704
author Hui-Bin Huang
Yi-Bing Zhu
Da-Xing Yu
author_facet Hui-Bin Huang
Yi-Bing Zhu
Da-Xing Yu
author_sort Hui-Bin Huang
collection DOAJ
description BackgroundSarcopenia has been shown to worsen survival after liver transplantation. However, it remains unclear whether coexisting sarcopenia and obesity, so-called sarcopenic obesity (SO), may also synergistically increase their adverse effects. This meta-analysis aimed to evaluate whether pre-transplant SO independently predicts survival in this population.MethodsWe conducted this study according to the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. The PubMed, Embase, Web of Science, Wanfang, CNKI, and Cochrane databases were searched up to 15 October 2023, for studies with any study design evaluating the relationship between SO and post-transplant survival in patients undergoing liver transplantation. We used ROBINS-E to assess the study quality. The primary outcome was all-cause mortality at any length of follow-up. We calculated pooled odds risks (ORs) or hazard risks (HRs) with 95% confidence intervals (CIs). Heterogeneity was quantified with I2 statistics. Subgroup analyses and publication bias evaluations were also conducted.ResultsWe included nine cohort studies with 2,416 patients. These studies were moderate to high quality. Pre-liver transplant patients commonly experience SO, with a mean prevalence as high as 34%. Overall, patients with SO exhibited a significantly higher overall mortality than patients without SO, as demonstrated by pooled studies using both univariate analysis [HR = 1.76, 95%C 1.33–2.33, p < 0.0001] and multivariate analysis (HR = 2.33, 95%CI 1.34–4.04, p = 0.003). Similar results were also found when comparing patients with or without SO at 1, 3, and 5 years of follow-up (OR = 1.86, 95%CI 1.22–2.83; OR = 1.83, 95%CI: 1.27–2.64; and OR = 1.54, 95% CI 1.02–2.34, respectively). In addition, subgroup analysis based on studies that reported HRs of both sarcopenia and SO indicated both had independent negative effects on post-transplant survival.ConclusionOur meta-analysis showed that SO occurs frequently in liver transplant patients. SO is associated with an increased risk of mortality in such patient populations.Systematic review registrationhttps://doi.org/10.37766/inplasy2024.2.0069 [inplasy2024.2.0069].
format Article
id doaj-art-3d56edc9c82147438ff17d3ad4c0fb50
institution Kabale University
issn 2296-861X
language English
publishDate 2024-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj-art-3d56edc9c82147438ff17d3ad4c0fb502024-12-16T16:41:06ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2024-12-011110.3389/fnut.2024.13876021387602Sarcopenic obesity is significantly associated with poorer overall survival after liver transplantation: a systematic review and meta-analysisHui-Bin HuangYi-Bing ZhuDa-Xing YuBackgroundSarcopenia has been shown to worsen survival after liver transplantation. However, it remains unclear whether coexisting sarcopenia and obesity, so-called sarcopenic obesity (SO), may also synergistically increase their adverse effects. This meta-analysis aimed to evaluate whether pre-transplant SO independently predicts survival in this population.MethodsWe conducted this study according to the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. The PubMed, Embase, Web of Science, Wanfang, CNKI, and Cochrane databases were searched up to 15 October 2023, for studies with any study design evaluating the relationship between SO and post-transplant survival in patients undergoing liver transplantation. We used ROBINS-E to assess the study quality. The primary outcome was all-cause mortality at any length of follow-up. We calculated pooled odds risks (ORs) or hazard risks (HRs) with 95% confidence intervals (CIs). Heterogeneity was quantified with I2 statistics. Subgroup analyses and publication bias evaluations were also conducted.ResultsWe included nine cohort studies with 2,416 patients. These studies were moderate to high quality. Pre-liver transplant patients commonly experience SO, with a mean prevalence as high as 34%. Overall, patients with SO exhibited a significantly higher overall mortality than patients without SO, as demonstrated by pooled studies using both univariate analysis [HR = 1.76, 95%C 1.33–2.33, p < 0.0001] and multivariate analysis (HR = 2.33, 95%CI 1.34–4.04, p = 0.003). Similar results were also found when comparing patients with or without SO at 1, 3, and 5 years of follow-up (OR = 1.86, 95%CI 1.22–2.83; OR = 1.83, 95%CI: 1.27–2.64; and OR = 1.54, 95% CI 1.02–2.34, respectively). In addition, subgroup analysis based on studies that reported HRs of both sarcopenia and SO indicated both had independent negative effects on post-transplant survival.ConclusionOur meta-analysis showed that SO occurs frequently in liver transplant patients. SO is associated with an increased risk of mortality in such patient populations.Systematic review registrationhttps://doi.org/10.37766/inplasy2024.2.0069 [inplasy2024.2.0069].https://www.frontiersin.org/articles/10.3389/fnut.2024.1387602/fullsarcopenic obesityliver transplantationmeta-analysissurvivalobesity
spellingShingle Hui-Bin Huang
Yi-Bing Zhu
Da-Xing Yu
Sarcopenic obesity is significantly associated with poorer overall survival after liver transplantation: a systematic review and meta-analysis
Frontiers in Nutrition
sarcopenic obesity
liver transplantation
meta-analysis
survival
obesity
title Sarcopenic obesity is significantly associated with poorer overall survival after liver transplantation: a systematic review and meta-analysis
title_full Sarcopenic obesity is significantly associated with poorer overall survival after liver transplantation: a systematic review and meta-analysis
title_fullStr Sarcopenic obesity is significantly associated with poorer overall survival after liver transplantation: a systematic review and meta-analysis
title_full_unstemmed Sarcopenic obesity is significantly associated with poorer overall survival after liver transplantation: a systematic review and meta-analysis
title_short Sarcopenic obesity is significantly associated with poorer overall survival after liver transplantation: a systematic review and meta-analysis
title_sort sarcopenic obesity is significantly associated with poorer overall survival after liver transplantation a systematic review and meta analysis
topic sarcopenic obesity
liver transplantation
meta-analysis
survival
obesity
url https://www.frontiersin.org/articles/10.3389/fnut.2024.1387602/full
work_keys_str_mv AT huibinhuang sarcopenicobesityissignificantlyassociatedwithpooreroverallsurvivalafterlivertransplantationasystematicreviewandmetaanalysis
AT yibingzhu sarcopenicobesityissignificantlyassociatedwithpooreroverallsurvivalafterlivertransplantationasystematicreviewandmetaanalysis
AT daxingyu sarcopenicobesityissignificantlyassociatedwithpooreroverallsurvivalafterlivertransplantationasystematicreviewandmetaanalysis